Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap11.06B
Enterprise Value10.62B
Trailing P/E18.85
Forward P/E9.33
GMED
(NYSE)Globus Medical, Inc.
$80.04-- (--)
Loading... - Market loading
Globus Medical (GMED) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)3.57
Forward Price/Sales2.89
Price/Book (mrq)2.34
Price/Tangible Book (mrq)4.30
Price/FCF (ttm)18.26
Price/OCF (ttm)14.21
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.42
EV/Earnings18.09
EV/EBITDA12.88
EV/EBIT19.67
EV/FCF17.53
Stock Price
Current price, 52-week range, and moving averages
Current Price$80.04
1-Day Change1.07%
52-Week High$101.40
52-Week Low$51.79
52-Week Change38.45%
YTD Change-8.32%
1-Year Change36.45%
50-Day MA$84.52
200-Day MA$81.10
Avg Volume (30 day)1.86M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding138.19M
Book Value per Share$34.24
Net Cash per Share$3.23
FCF per Share$4.38
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$113.29
Target Upside/Downside41.54%
Analyst ConsensusBuy
Analyst Count8
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin68.82%
EBITDA Margin (ttm)26.58%
EBIT Margin (ttm)17.40%
Operating Margin (ttm)17.62%
Pretax Margin (ttm)21.39%
Profit Margin (ttm)18.92%
FCF Margin (ttm)19.53%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)12.40%
Return on Assets (ttm)10.79%
Return on Invested Capital (ttm)11.13%
Return on Capital Employed (ttm)10.88%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue3.10B
Gross Profit2.13B
Operating Income546.37M
Pretax Income663.31M
Net Income586.74M
EBITDA824.20M
EBIT539.55M
Diluted EPS$4.29
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow778.51M
Capital Expenditures172.94M
Free Cash Flow605.57M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth23.49%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)5.44B
Cash & Securities (mrq)560.95M
Net Cash (mrq)445.73M
Net Cash per Share$3.23
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)115.22M
Working Capital (mrq)1.72B
Total Equity (mrq)4.73B
Book Value per Share$34.24
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)4.56
Quick Ratio (mrq)2.95
Debt/Equity (mrq)0.02
Debt/EBITDA (ttm)0.14
Debt/FCF (ttm)0.19
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield5.30%
FCF Yield5.47%
Buyback Yield0.06%
Total Shareholder Yield0.06%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score10.67
Piotroski F-Score8/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$57.48
Graham Upside/Downside-28.18%
Frequently Asked Questions About Globus Medical Statistics
What are the key financial metrics for GMED?
Globus Medical, Inc. (GMED) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is GMED's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Globus Medical is overvalued or undervalued.
How do I read GMED's profitability ratios?
Globus Medical's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do GMED's debt ratios indicate?
The financial health section shows Globus Medical's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is GMED's dividend analysis?
The dividend section covers Globus Medical's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.